Trademark: THE FORSYTHE LITE LOW-DOSE CHEMO INSULIN POTENTIATED THERAPY (LDIPT) PROTOCOL
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Track updates on THE FORSYTHE LITE LOW-DOSE CHEMO INSULIN POTENTIATED THERAPY (LDIPT) PROTOCOL
Mark Identification
THE FORSYTHE LITE LOW-DOSE CHEMO INSULIN POTENTIATED THERAPY (LDIPT) PROTOCOL
Proof of use for THE FORSYTHE LITE LOW-DOSE CHEMO INSULIN POTENTIATED THERAPY (LDIPT) PROTOCOL
We do not have any records of a proof of use for THE FORSYTHE LITE LOW-DOSE CHEMO INSULIN POTENTIATED THERAPY (LDIPT) PROTOCOL at this moment.
Possible trademark infringements of THE FORSYTHE LITE LOW-DOSE CHEMO INSULIN POTENTIATED THERAPY (LDIPT) PROTOCOL
Basic Information about THE FORSYTHE LITE LOW-DOSE CHEMO INSULIN POTENTIATED THERAPY (LDIPT) PROTOCOL
- Serial Number
- 86230511
- Filing Date
- 24 Mar 2014
- Registration Number
- 4730261
- Registration Date
- 05 May 2015
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of THE FORSYTHE LITE LOW-DOSE CHEMO INSULIN POTENTIATED THERAPY (LDIPT) PROTOCOL on the blockchain with WikiTrademarks.io.
- First use of THE FORSYTHE LITE LOW-DOSE CHEMO INSULIN POTENTIATED THERAPY (LDIPT) PROTOCOL anywhere
- THE FORSYTHE LITE LOW-DOSE CHEMO INSULIN POTENTIATED THERAPY (LDIPT) PROTOCOL was first used on 01 Jun 2007 for the primary classification of goods and services, international, 044 (Medical, beauty & agricultural)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 2
- International Code
- 044
- US Codes
- 100; 101
Who owns THE FORSYTHE LITE LOW-DOSE CHEMO INSULIN POTENTIATED THERAPY (LDIPT) PROTOCOL?
1. Forsythe, James. W. M.D. Reno NV
2. Forsythe, James. W. M.D. Reno NV
3. Forsythe, James. W. M.D. Reno NV
Correspondent
- MARIE MIRCH
- MIRCH LAW FIRM, LLP
- 750 B ST STE 2500
- SAN DIEGO, CA 92101-8106
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io
Track updates on THE FORSYTHE LITE LOW-DOSE CHEMO INSULIN POTENTIATED THERAPY (LDIPT) PROTOCOL